Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum93142Research ArticleB-ADRENOBLOKATORY I KOMBINIROVANNYE NIZKODOZOVYE PREPARATY PRI LEChENII ARTERIAL'NOY GIPERTONIIStryukR. I-15052010125242728122021Copyright © 2010, Consilium Medicum2010[Ивлева А.Я., Сивкова Е.Б. Современные представления о клинической ценности b - адреноблокаторов. М., 2004.][Elliott W, Meyer P. Incident diabetes in clinical trial of antihypertensive drugs:a network meta - analysis. Lancet 2007; 369: 201–7.][Benetos A, Consoli S, Safavian A et al. Efficacy,safety and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension. Am Heart J 2000; 140 (4): E11.][Haasis R, Bethge H. Exercise blood pressure and heart rate reduction 24 and 3 hours after drug intake in hypertensive patients following 4 weeks of treatment with bisoprolol and metoprolol: a randomized multicentre double - blind study (BISOMET). Eur Heart J 1987; 8: 103–13.][Buhtel F.R, Berglund G, Anderson O.K et al. Smoking status and cardioselective beta - blocade antihypertensive therapy: the Bisoprolol International Multicentre Study (BIMS). J Hypertens 1986; 4: 144–6.][Van der Ven L.M. Age - dependent differences in the efficacy and tolerability of different classes of antihypertensive drugs. Clin Drug Invest 1997; 1: 16–22.][Blood Pressure Lowering Treatment Trialists\' Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta - analysis of randomised trials. BMJ 2008; 336: 1121–3.][Ситникова М.Ю., Иванов С.Г., Хмельницкая К.А. Плейотропные эффекты b - адреноблокаторов в терапии сердечно - сосудистых заболеваний: влияние на перекисное окисление липидов, свойства эндотелия и эволюцию атеросклероза. Кардиология. 2009; 6: 61–6.][SHEP Cooperative Reseach Group. Prevention of stroke by antihypertensive drug treatment in older person withisolated systolis hypertension. Final results of the Systolic Hypertension in Elderly Program (SHEP). JAMA 1991; 265: 3255–64.][Bakris G, Molitch M, Hewkin A et al. Sowers. STAR investigators. Differences in glucose tolerance between fixed (dose antihypertensive drug combinations in people with metabolic syndrome. Diabetes Care 2006; 29: 2592–7.][Fernandez R, Puig J.G, Rodriguez-Perez J. et al., on behalf of the TRAVEND Study Group. Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double - blind study. J Human Hypertens 2001; 15: 849–56.][Диагностика и лечение артериальной гипертензии. Российские рекомендации. Кардиоваск. тер. и проф. 2008; Прил. 2.][Frishman W.H, Burris J.F, Mroczek W.J. et al. First - line therapy jhtion with lowedose Bisoprolol fumarate and lowe - dose Hydrochlorothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol 1995; 35: 182–8.]